Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells.
about
The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.Deregulated microRNAs in multiple myeloma.Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells.Paired box gene 5 may modulate Proviral Integration of Moloney virus 2 gene and protein expression in mature B-cells.Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 infection.X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas.EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency.
P2860
Q34097631-196A52C7-CAF7-4A0D-91D2-1D346BD4D39BQ34627655-15793A7A-8265-4CF6-AD97-B5236040F8C6Q37916411-DF47CF00-061D-4C5E-8F5D-4235B84F6D8EQ38822694-08017831-3AAC-43A3-8C72-7D8D7845B062Q39036600-2575970F-5FD5-4620-98F8-BAF51F72A5DDQ39596708-1B026277-3B61-401A-83DB-9A1622DA2506Q39621362-9233AA2D-A3D3-4C3F-89E5-67073227054EQ39639121-B384E6F6-B45D-4D67-BC10-BCFC1EAC1F45Q40375799-1A475384-149F-4994-9E78-6AE108128D96Q42105764-6D63FEC3-2DEB-44D6-9F79-21D67881507CQ43225878-EA977567-8AD5-4958-804D-63D5D8930944
P2860
Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@en
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@nl
type
label
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@en
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@nl
prefLabel
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@en
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@nl
P2093
P1433
P1476
Epstein-Barr virus infection l ...... ferentiated malignant B cells.
@en
P2093
Alberto Faggioni
Carlo Presutti
Eleni Anastasiadou
Francesco Boccellato
Gösta Winberg
Laura Cuomo
Luigi Frati
Mara Cirone
Pankaj Trivedi
Paul A Wade
P304
P356
10.1016/J.CANLET.2009.04.025
P407
P577
2009-05-28T00:00:00Z